English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

The search for newer antimicrobial agents is a developing and continuing process. With an aim to discover new antimalarial leads from natural sources, a unique lichen-derived metabolite namely, usnic acid (USA) and their analogues were screened against a chloroquine-sensitive  Plasmodium falciparum  3D7 line using an  in vitro  parasite growth inhibition assay. A bio guided fractionation of USA, the molecule of interest, derived from the ether extract of the lichen,  Usnea undulata , reported to exhibit significant protease enzyme inhibitory activity, was used as a natural product scaffold and was chemically modified to yield three hydrazine, viz usnic acid anhydro phenyl hydrazone (S1), usnic acid anhydro 4-nitro phenyl hydrazone (S2), usnic acid anhydro 2,4-dinitro phenyl hydrazone (S3) and two amino compounds namely usnic acid anhydro o-phenylene diamine derivative (S5) and usnic acid anhydro piperazine derivative (S6) respectively. These low molecular weight non-peptidyl newer chemical entities (USA, S1, S2, S3, S5 and S6) were tested  in vitro  against the malaria parasite,  Plasmodium falciparum  and among all, the hydrazine moiety, usnic acid anhydro 4-nitro phenyl hydrazone (S2) was shown to the most active compound with an IC 50  of 1.4·10 −5  M when compared to the parent pharmacophore, USA with an IC 50  of 6.5·10 −5  M. The results reveal that lichen metabolite; USA offers a large scaffold for combinatorial outputs in developing lead candidates with potent antimalarial activity.

Low Molecular Weight Non-Peptidyl Antimalarial Leads: Lichen Metabolite, Usnic Acid and Its Analogues